Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Here, you'll find ... disease, two studies within the pain management program, and a type 1 diabetes candidate. Of course, anything can happen at any stage in a clinical trial, so it's possible that ...

This company is a leader in two major areas, and these businesses are generating billion-dollar revenue. The stock looks very ...

OpenAI has finalized a deal to sell employees’ shares to investors that values the artificial intelligence company at $500 ...

Cystic fibrosis patients rarely used to see age 30. Now, with this Iowa doctor's work, people are living well into their 80s — and even running.

That's when Klein decided to give his corporate clients an ultimatum: Migrate your data to our cloud products, or we will no ...

In about one out of every 800 people, two chromosomes fuse together to form an unusual bond. These are known as Robertsonian chromosomes. It's a mystery that has long stumped scientists.

New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...

Forget what you think you know. Our lab tests reveal surprising links between battery life, price, suction and weight.